Incyte (INCY) News Today $78.39 +0.19 (+0.24%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$78.19 -0.20 (-0.26%) As of 08/8/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Bank of Nova Scotia Sells 4,777 Shares of Incyte Corporation (NASDAQ:INCY)August 9 at 4:09 AM | marketbeat.comIncyte Corporation (NASDAQ:INCY) Stock Position Raised by Natixis Advisors LLCAugust 9 at 3:46 AM | marketbeat.comIncyte (NASDAQ:INCY) Upgraded at Wells Fargo & CompanyAugust 9 at 2:31 AM | americanbankingnews.comAnalysts Conflicted on These Healthcare Names: Incyte (INCY) and Y-Mabs Therapeutics (YMAB)August 8 at 6:17 PM | theglobeandmail.comOntario Teachers Pension Plan Board Purchases 55,899 Shares of Incyte Corporation (NASDAQ:INCY)August 8 at 6:43 AM | marketbeat.comImpressive Earnings May Not Tell The Whole Story For Incyte (NASDAQ:INCY)August 7 at 8:56 PM | finance.yahoo.comIncyte Corporation (INCY) Announces CFO DepartureAugust 7 at 10:34 AM | gurufocus.comIncyte CFO Christiana Stamoulis to Step DownAugust 7 at 9:51 AM | tipranks.comIncyte (NASDAQ:INCY) Upgraded to Overweight at Wells Fargo & CompanyAugust 7 at 8:48 AM | marketbeat.comWells Fargo Upgrades Incyte (INCY)August 7 at 2:20 AM | msn.comTop Incyte Executive Sells Hundreds of Shares!August 6 at 10:17 PM | tipranks.comActuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on ...August 6 at 10:01 AM | gurufocus.comIncyte Announces Departure of Chief Financial Officer Christiana StamoulisAugust 5, 2025 | businesswire.comIncyte Corporation (NASDAQ:INCY) Shares Sold by JGP Global Gestao de Recursos Ltda.August 5, 2025 | marketbeat.comKnight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin AmericaAugust 4, 2025 | financialpost.comFIncyte’s Phase 1 Study Update: A Potential Game-Changer in Cancer TreatmentAugust 4, 2025 | tipranks.comIncyte’s Phase 1 Study on INCB054707: A Potential Game-Changer for Hepatic ImpairmentAugust 4, 2025 | tipranks.comIncyte’s Promising Study Completion: Tafasitamab and Parsaclisib in B-cell MalignanciesAugust 4, 2025 | tipranks.comIncyte’s INCB000928 Study Completion: A Potential Game-Changer for Anemia TreatmentAugust 4, 2025 | tipranks.comIncyte Corporation (NASDAQ:INCY) Shares Sold by DCF Advisers LLCAugust 4, 2025 | marketbeat.comBlueshift Asset Management LLC Invests $206,000 in Incyte Corporation (NASDAQ:INCY)August 4, 2025 | marketbeat.comGSA Capital Partners LLP Increases Stock Position in Incyte Corporation (NASDAQ:INCY)August 4, 2025 | marketbeat.comAnalysts Set Incyte Corporation (NASDAQ:INCY) PT at $77.73August 4, 2025 | americanbankingnews.comBarclays Begins Coverage on Incyte (NASDAQ:INCY)August 4, 2025 | americanbankingnews.comIncyte (INCY) Leads Healthcare Gains Despite Market DipAugust 3, 2025 | gurufocus.comJupiter Asset Management Ltd. Increases Stock Position in Incyte Corporation (NASDAQ:INCY)August 3, 2025 | marketbeat.comLSV Asset Management Has $220.28 Million Stake in Incyte Corporation (NASDAQ:INCY)August 3, 2025 | marketbeat.comIncyte (INCY) Gets a Buy from Stifel NicolausAugust 2, 2025 | theglobeandmail.comIncyte (NASDAQ:INCY) Earns Overweight Rating from Analysts at BarclaysAugust 2, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Shares Bought by Jefferies Financial Group Inc.August 2, 2025 | marketbeat.comFoundations Investment Advisors LLC Purchases 5,546 Shares of Incyte Corporation (NASDAQ:INCY)August 2, 2025 | marketbeat.comTD Asset Management Inc Grows Position in Incyte Corporation (NASDAQ:INCY)August 2, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Shares Sold by Pacer Advisors Inc.August 2, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Price Target Raised to $79.00August 2, 2025 | americanbankingnews.comThis Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For FridayAugust 1, 2025 | benzinga.comIncyte (INCY) Receives Overweight Rating and $90 Price Target from BarclaysAugust 1, 2025 | gurufocus.comFederated Hermes Inc. Has $43.01 Million Stock Holdings in Incyte Corporation (NASDAQ:INCY)August 1, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Given Average Recommendation of "Hold" by BrokeragesAugust 1, 2025 | marketbeat.comKnight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in BrazilJuly 31, 2025 | globenewswire.comIncyte (NASDAQ:INCY) Given New $103.00 Price Target at CitigroupJuly 31, 2025 | marketbeat.comBMO Capital Markets Raises Incyte (NASDAQ:INCY) Price Target to $60.00July 31, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Stock Price Expected to Rise, Truist Financial Analyst SaysJuly 31, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Price Target Raised to $68.00 at UBS GroupJuly 31, 2025 | marketbeat.comWells Fargo & Company Increases Incyte (NASDAQ:INCY) Price Target to $67.00July 31, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Price Target Raised to $72.00 at Royal Bank Of CanadaJuly 31, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Stock Holdings Lowered by GS Investments Inc.July 31, 2025 | marketbeat.comClark Estates Inc. NY Trims Position in Incyte Corporation (NASDAQ:INCY)July 31, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Holdings Raised by Mackenzie Financial CorpJuly 31, 2025 | marketbeat.com1INCY : The Analyst Verdict: Incyte In The Eyes Of 10 ExpertsJuly 31, 2025 | benzinga.comIncyte (NASDAQ:INCY) Trading Up 7.5% - Time to Buy?July 30, 2025 | marketbeat.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.780.45▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼2818▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AbbVie News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exelixis News Today Exact Sciences News Today Halozyme Therapeutics News Today Ionis Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INCY Stock Alerts